Ulvestad et al. reported that, of 15 primary CAD patients, nine showed decreased serum C3, 11 showed C4, and six showed reduced CH50, indicating that patients with CAD experience continuous complement consumption [13]. The gene discussed is C3; the disease is cold agglutinin disease.